nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—chronic obstructive pulmonary disease	0.57	1	CbGaD
Amiloride—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.164	1	CbGbCtD
Amiloride—SCNN1G—sweat—chronic obstructive pulmonary disease	0.0284	0.372	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—SERPINE2—chronic obstructive pulmonary disease	0.00554	0.0546	CbGpPWpGaD
Amiloride—ASIC2—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00361	0.0356	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00274	0.027	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00274	0.027	CbGpPWpGaD
Amiloride—SCNN1G—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00274	0.027	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00274	0.027	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00274	0.027	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ELANE—chronic obstructive pulmonary disease	0.00266	0.0262	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00264	0.0261	CbGpPWpGaD
Amiloride—SCNN1G—respiratory system—chronic obstructive pulmonary disease	0.00255	0.0334	CbGeAlD
Amiloride—SCNN1D—respiratory system—chronic obstructive pulmonary disease	0.00255	0.0334	CbGeAlD
Amiloride—SLC9A1—respiratory system—chronic obstructive pulmonary disease	0.0024	0.0314	CbGeAlD
Amiloride—ASIC2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00236	0.0232	CbGpPWpGaD
Amiloride—PLAU—respiratory system—chronic obstructive pulmonary disease	0.00228	0.0298	CbGeAlD
Amiloride—AOC1—connective tissue—chronic obstructive pulmonary disease	0.00221	0.0289	CbGeAlD
Amiloride—SCNN1B—respiratory system—chronic obstructive pulmonary disease	0.00216	0.0282	CbGeAlD
Amiloride—SLC9A1—connective tissue—chronic obstructive pulmonary disease	0.00211	0.0277	CbGeAlD
Amiloride—SCNN1G—bronchus—chronic obstructive pulmonary disease	0.0021	0.0275	CbGeAlD
Amiloride—AOC1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00203	0.02	CbGpPWpGaD
Amiloride—PLAU—connective tissue—chronic obstructive pulmonary disease	0.002	0.0262	CbGeAlD
Amiloride—SCNN1D—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.002	0.0197	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.002	0.0197	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.002	0.0197	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.002	0.0197	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.002	0.0197	CbGpPWpGaD
Amiloride—SCNN1A—respiratory system—chronic obstructive pulmonary disease	0.00199	0.0261	CbGeAlD
Amiloride—SLC9A1—bronchus—chronic obstructive pulmonary disease	0.00198	0.0259	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—PLAUR—chronic obstructive pulmonary disease	0.00195	0.0192	CbGpPWpGaD
Amiloride—SLC9A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00193	0.0253	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP12—chronic obstructive pulmonary disease	0.00189	0.0187	CbGpPWpGaD
Amiloride—PLAU—bronchus—chronic obstructive pulmonary disease	0.00187	0.0245	CbGeAlD
Amiloride—PLAU—smooth muscle tissue—chronic obstructive pulmonary disease	0.00183	0.024	CbGeAlD
Amiloride—ASIC1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00178	0.0176	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00178	0.0176	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00178	0.0176	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00178	0.0176	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00178	0.0176	CbGpPWpGaD
Amiloride—SCNN1B—bronchus—chronic obstructive pulmonary disease	0.00178	0.0232	CbGeAlD
Amiloride—PLAU—trachea—chronic obstructive pulmonary disease	0.00168	0.022	CbGeAlD
Amiloride—SCNN1A—bronchus—chronic obstructive pulmonary disease	0.00164	0.0215	CbGeAlD
Amiloride—SCNN1B—trachea—chronic obstructive pulmonary disease	0.00159	0.0209	CbGeAlD
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.00157	0.0155	CbGpPWpGaD
Amiloride—AOC1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00147	0.0145	CbGpPWpGaD
Amiloride—SCNN1A—trachea—chronic obstructive pulmonary disease	0.00147	0.0193	CbGeAlD
Amiloride—SCNN1G—lung—chronic obstructive pulmonary disease	0.00136	0.0177	CbGeAlD
Amiloride—SCNN1D—lung—chronic obstructive pulmonary disease	0.00136	0.0177	CbGeAlD
Amiloride—SLC9A1—lung—chronic obstructive pulmonary disease	0.00128	0.0167	CbGeAlD
Amiloride—PLAU—lung—chronic obstructive pulmonary disease	0.00121	0.0158	CbGeAlD
Amiloride—SCNN1B—lung—chronic obstructive pulmonary disease	0.00115	0.015	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—CTGF—chronic obstructive pulmonary disease	0.00113	0.0111	CbGpPWpGaD
Amiloride—SCNN1A—lung—chronic obstructive pulmonary disease	0.00106	0.0139	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—SERPINE1—chronic obstructive pulmonary disease	0.00106	0.0104	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.00103	0.0101	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—PLAUR—chronic obstructive pulmonary disease	0.000948	0.00935	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00092	0.00907	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—chronic obstructive pulmonary disease	0.000844	0.00832	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000842	0.00831	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.000829	0.00817	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00082	0.00808	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—MMP9—chronic obstructive pulmonary disease	0.00081	0.00799	CbGpPWpGaD
Amiloride—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.000799	0.0105	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—chronic obstructive pulmonary disease	0.000763	0.00752	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—HMOX1—chronic obstructive pulmonary disease	0.000761	0.00751	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.000748	0.00738	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000718	0.00709	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000697	0.00687	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000697	0.00687	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000697	0.00687	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000697	0.00687	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000697	0.00687	CbGpPWpGaD
Amiloride—PLAU—Blood Clotting Cascade—SERPINE1—chronic obstructive pulmonary disease	0.000694	0.00685	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—TGFB2—chronic obstructive pulmonary disease	0.000673	0.00664	CbGpPWpGaD
Amiloride—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.000657	0.0086	CbGeAlD
Amiloride—PLAU—FGF signaling pathway—KL—chronic obstructive pulmonary disease	0.000643	0.00634	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.00063	0.00622	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—PLAUR—chronic obstructive pulmonary disease	0.000624	0.00615	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000621	0.00613	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000621	0.00613	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000621	0.00613	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000621	0.00613	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000621	0.00613	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—chronic obstructive pulmonary disease	0.000603	0.00595	CbGpPWpGaD
Amiloride—SLC22A4—trachea—chronic obstructive pulmonary disease	0.00059	0.00772	CbGeAlD
Amiloride—PLAU—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.000581	0.00573	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MMP14—chronic obstructive pulmonary disease	0.000556	0.00548	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.000531	0.00524	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000531	0.253	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000531	0.253	CbGdCrCtD
Amiloride—Thirst—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00608	CcSEcCtD
Amiloride—SLC9A1—Endothelins—EDN1—chronic obstructive pulmonary disease	0.00052	0.00513	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.247	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.247	CbGdCrCtD
Amiloride—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.00591	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000459	0.00453	CbGpPWpGaD
Amiloride—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00532	CcSEcCtD
Amiloride—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00532	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000449	0.00521	CcSEcCtD
Amiloride—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00521	CcSEcCtD
Amiloride—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000445	0.00517	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—chronic obstructive pulmonary disease	0.000437	0.00431	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—MMP1—chronic obstructive pulmonary disease	0.000437	0.00431	CbGpPWpGaD
Amiloride—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000433	0.00503	CcSEcCtD
Amiloride—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00502	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000431	0.00425	CbGpPWpGaD
Amiloride—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00497	CcSEcCtD
Amiloride—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00497	CcSEcCtD
Amiloride—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000428	0.00497	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000426	0.0042	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000425	0.00494	CcSEcCtD
Amiloride—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000425	0.00493	CcSEcCtD
Amiloride—SLC22A4—lung—chronic obstructive pulmonary disease	0.000424	0.00555	CbGeAlD
Amiloride—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000421	0.00489	CcSEcCtD
Amiloride—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00488	CcSEcCtD
Amiloride—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00485	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—chronic obstructive pulmonary disease	0.000414	0.00408	CbGpPWpGaD
Amiloride—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00479	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00041	0.00404	CbGpPWpGaD
Amiloride—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00474	CcSEcCtD
Amiloride—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000406	0.00471	CcSEcCtD
Amiloride—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00469	CcSEcCtD
Amiloride—PLAU—Osteopontin-mediated events—MMP9—chronic obstructive pulmonary disease	0.000404	0.00399	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000403	0.00468	CcSEcCtD
Amiloride—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.00458	CcSEcCtD
Amiloride—PLAU—amb2 Integrin signaling—MMP9—chronic obstructive pulmonary disease	0.000394	0.00389	CbGpPWpGaD
Amiloride—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00454	CcSEcCtD
Amiloride—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000389	0.00452	CcSEcCtD
Amiloride—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00451	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—chronic obstructive pulmonary disease	0.000388	0.00383	CbGpPWpGaD
Amiloride—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00438	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000374	0.00369	CbGpPWpGaD
Amiloride—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00434	CcSEcCtD
Amiloride—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00426	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000362	0.00357	CbGpPWpGaD
Amiloride—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00419	CcSEcCtD
Amiloride—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000356	0.00413	CcSEcCtD
Amiloride—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000353	0.0041	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—chronic obstructive pulmonary disease	0.000351	0.00346	CbGpPWpGaD
Amiloride—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00394	CcSEcCtD
Amiloride—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00394	CcSEcCtD
Amiloride—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000337	0.00391	CcSEcCtD
Amiloride—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00389	CcSEcCtD
Amiloride—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00388	CcSEcCtD
Amiloride—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00386	CcSEcCtD
Amiloride—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000331	0.00384	CcSEcCtD
Amiloride—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000326	0.00378	CcSEcCtD
Amiloride—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00375	CcSEcCtD
Amiloride—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00375	CcSEcCtD
Amiloride—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00375	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—chronic obstructive pulmonary disease	0.000317	0.00313	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.000315	0.00311	CbGpPWpGaD
Amiloride—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000313	0.00364	CcSEcCtD
Amiloride—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00363	CcSEcCtD
Amiloride—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00031	0.00361	CcSEcCtD
Amiloride—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00031	0.0036	CcSEcCtD
Amiloride—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0036	CcSEcCtD
Amiloride—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000308	0.00358	CcSEcCtD
Amiloride—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00354	CcSEcCtD
Amiloride—PLAU—amb2 Integrin signaling—TNF—chronic obstructive pulmonary disease	0.000303	0.00299	CbGpPWpGaD
Amiloride—Tension—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00349	CcSEcCtD
Amiloride—Tension—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00349	CcSEcCtD
Amiloride—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00345	CcSEcCtD
Amiloride—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00345	CcSEcCtD
Amiloride—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.00345	CcSEcCtD
Amiloride—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00344	CcSEcCtD
Amiloride—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00344	CcSEcCtD
Amiloride—PLAU—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000296	0.00292	CbGpPWpGaD
Amiloride—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00342	CcSEcCtD
Amiloride—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00342	CcSEcCtD
Amiloride—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000292	0.0034	CcSEcCtD
Amiloride—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00337	CcSEcCtD
Amiloride—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00336	CcSEcCtD
Amiloride—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00335	CcSEcCtD
Amiloride—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00333	CcSEcCtD
Amiloride—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00333	CcSEcCtD
Amiloride—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00331	CcSEcCtD
Amiloride—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00331	CcSEcCtD
Amiloride—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00329	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.00328	CcSEcCtD
Amiloride—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00326	CcSEcCtD
Amiloride—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00326	CcSEcCtD
Amiloride—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00325	CcSEcCtD
Amiloride—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00325	CcSEcCtD
Amiloride—PLAU—Beta3 integrin cell surface interactions—VEGFA—chronic obstructive pulmonary disease	0.000279	0.00275	CbGpPWpGaD
Amiloride—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00323	CcSEcCtD
Amiloride—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00323	CcSEcCtD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000276	0.00272	CbGpPWpGaD
Amiloride—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00317	CcSEcCtD
Amiloride—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00315	CcSEcCtD
Amiloride—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00314	CcSEcCtD
Amiloride—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00314	CcSEcCtD
Amiloride—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00312	CcSEcCtD
Amiloride—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.0031	CcSEcCtD
Amiloride—Cough—Formoterol—chronic obstructive pulmonary disease	0.000267	0.0031	CcSEcCtD
Amiloride—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.0031	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000267	0.00263	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000266	0.00262	CbGpPWpGaD
Amiloride—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00308	CcSEcCtD
Amiloride—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00308	CcSEcCtD
Amiloride—Cough—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00304	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—chronic obstructive pulmonary disease	0.000261	0.00258	CbGpPWpGaD
Amiloride—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00303	CcSEcCtD
Amiloride—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00303	CcSEcCtD
Amiloride—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00303	CcSEcCtD
Amiloride—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00303	CcSEcCtD
Amiloride—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00302	CcSEcCtD
Amiloride—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00301	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—MMP9—chronic obstructive pulmonary disease	0.000259	0.00256	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000259	0.00255	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—chronic obstructive pulmonary disease	0.000256	0.00253	CbGpPWpGaD
Amiloride—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00297	CcSEcCtD
Amiloride—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00297	CcSEcCtD
Amiloride—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00294	CcSEcCtD
Amiloride—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00293	CcSEcCtD
Amiloride—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00286	CcSEcCtD
Amiloride—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00286	CcSEcCtD
Amiloride—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00284	CcSEcCtD
Amiloride—PLAU—amb2 Integrin signaling—IL6—chronic obstructive pulmonary disease	0.000245	0.00241	CbGpPWpGaD
Amiloride—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00282	CcSEcCtD
Amiloride—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00278	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000233	0.0023	CbGpPWpGaD
Amiloride—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.0027	CcSEcCtD
Amiloride—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.0027	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00264	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00264	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—MMP9—chronic obstructive pulmonary disease	0.000226	0.00223	CbGpPWpGaD
Amiloride—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00262	CcSEcCtD
Amiloride—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00262	CcSEcCtD
Amiloride—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00261	CcSEcCtD
Amiloride—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00261	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00259	CcSEcCtD
Amiloride—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00259	CcSEcCtD
Amiloride—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00259	CcSEcCtD
Amiloride—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00258	CcSEcCtD
Amiloride—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00258	CcSEcCtD
Amiloride—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00257	CcSEcCtD
Amiloride—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00255	CcSEcCtD
Amiloride—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00255	CcSEcCtD
Amiloride—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00255	CcSEcCtD
Amiloride—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00254	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—chronic obstructive pulmonary disease	0.000218	0.00215	CbGpPWpGaD
Amiloride—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00253	CcSEcCtD
Amiloride—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000217	0.00252	CcSEcCtD
Amiloride—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00251	CcSEcCtD
Amiloride—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00251	CcSEcCtD
Amiloride—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000215	0.0025	CcSEcCtD
Amiloride—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000215	0.0025	CcSEcCtD
Amiloride—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.0025	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.0025	CcSEcCtD
Amiloride—Pain—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00248	CcSEcCtD
Amiloride—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00248	CcSEcCtD
Amiloride—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00248	CcSEcCtD
Amiloride—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00248	CcSEcCtD
Amiloride—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00248	CcSEcCtD
Amiloride—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00246	CcSEcCtD
Amiloride—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00245	CcSEcCtD
Amiloride—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00245	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000211	0.00208	CbGpPWpGaD
Amiloride—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00244	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00021	0.00207	CbGpPWpGaD
Amiloride—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00244	CcSEcCtD
Amiloride—Pain—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00243	CcSEcCtD
Amiloride—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00242	CcSEcCtD
Amiloride—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00241	CcSEcCtD
Amiloride—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.0024	CcSEcCtD
Amiloride—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.0024	CcSEcCtD
Amiloride—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00239	CcSEcCtD
Amiloride—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00239	CcSEcCtD
Amiloride—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.00239	CcSEcCtD
Amiloride—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00238	CcSEcCtD
Amiloride—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00238	CcSEcCtD
Amiloride—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00237	CcSEcCtD
Amiloride—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00237	CcSEcCtD
Amiloride—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00237	CcSEcCtD
Amiloride—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00236	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—VEGFA—chronic obstructive pulmonary disease	0.000203	0.002	CbGpPWpGaD
Amiloride—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00234	CcSEcCtD
Amiloride—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00234	CcSEcCtD
Amiloride—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00232	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00232	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—SERPINE1—chronic obstructive pulmonary disease	0.000199	0.00196	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—chronic obstructive pulmonary disease	0.000198	0.00196	CbGpPWpGaD
Amiloride—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00229	CcSEcCtD
Amiloride—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00229	CcSEcCtD
Amiloride—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00229	CcSEcCtD
Amiloride—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00227	CcSEcCtD
Amiloride—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00227	CcSEcCtD
Amiloride—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00226	CcSEcCtD
Amiloride—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00226	CcSEcCtD
Amiloride—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00225	CcSEcCtD
Amiloride—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00225	CcSEcCtD
Amiloride—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00225	CcSEcCtD
Amiloride—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00224	CcSEcCtD
Amiloride—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00222	CcSEcCtD
Amiloride—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00221	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000187	0.00185	CbGpPWpGaD
Amiloride—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00217	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—TGFB1—chronic obstructive pulmonary disease	0.000187	0.00184	CbGpPWpGaD
Amiloride—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.00214	CcSEcCtD
Amiloride—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00213	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00018	0.00178	CbGpPWpGaD
Amiloride—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00208	CcSEcCtD
Amiloride—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00208	CcSEcCtD
Amiloride—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00205	CcSEcCtD
Amiloride—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00205	CcSEcCtD
Amiloride—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00205	CcSEcCtD
Amiloride—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00204	CcSEcCtD
Amiloride—SLC9A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000175	0.00173	CbGpPWpGaD
Amiloride—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00202	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000174	0.00171	CbGpPWpGaD
Amiloride—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00201	CcSEcCtD
Amiloride—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00199	CcSEcCtD
Amiloride—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00199	CcSEcCtD
Amiloride—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00197	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CXCL8—chronic obstructive pulmonary disease	0.000168	0.00166	CbGpPWpGaD
Amiloride—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00194	CcSEcCtD
Amiloride—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00194	CcSEcCtD
Amiloride—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00192	CcSEcCtD
Amiloride—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00192	CcSEcCtD
Amiloride—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00188	CcSEcCtD
Amiloride—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00188	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—chronic obstructive pulmonary disease	0.000162	0.00159	CbGpPWpGaD
Amiloride—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00187	CcSEcCtD
Amiloride—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00185	CcSEcCtD
Amiloride—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00185	CcSEcCtD
Amiloride—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00185	CcSEcCtD
Amiloride—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00183	CcSEcCtD
Amiloride—Rash—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00183	CcSEcCtD
Amiloride—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00183	CcSEcCtD
Amiloride—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00183	CcSEcCtD
Amiloride—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00182	CcSEcCtD
Amiloride—Headache—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00182	CcSEcCtD
Amiloride—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00181	CcSEcCtD
Amiloride—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00181	CcSEcCtD
Amiloride—Rash—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00179	CcSEcCtD
Amiloride—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00179	CcSEcCtD
Amiloride—Depression—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00179	CcSEcCtD
Amiloride—Headache—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00178	CcSEcCtD
Amiloride—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00174	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.00015	0.00148	CbGpPWpGaD
Amiloride—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00173	CcSEcCtD
Amiloride—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00173	CcSEcCtD
Amiloride—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00173	CcSEcCtD
Amiloride—PLAU—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000148	0.00146	CbGpPWpGaD
Amiloride—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00172	CcSEcCtD
Amiloride—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00172	CcSEcCtD
Amiloride—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00172	CcSEcCtD
Amiloride—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00169	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000143	0.00141	CbGpPWpGaD
Amiloride—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00164	CcSEcCtD
Amiloride—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00163	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00162	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00161	CcSEcCtD
Amiloride—SCNN1B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00135	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	0.000136	0.00135	CbGpPWpGaD
Amiloride—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00155	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000131	0.00129	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000129	0.00127	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	0.000126	0.00124	CbGpPWpGaD
Amiloride—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00142	CcSEcCtD
Amiloride—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00142	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—chronic obstructive pulmonary disease	0.000122	0.0012	CbGpPWpGaD
Amiloride—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00141	CcSEcCtD
Amiloride—SLC9A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000116	0.00115	CbGpPWpGaD
Amiloride—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00134	CcSEcCtD
Amiloride—PLAU—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000115	0.00114	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000113	0.00111	CbGpPWpGaD
Amiloride—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.0013	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000108	0.00107	CbGpPWpGaD
Amiloride—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00126	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000107	0.00105	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—chronic obstructive pulmonary disease	0.000106	0.00104	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000105	0.00104	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000105	0.00104	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000104	0.00103	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	0.000103	0.00102	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.000103	0.00102	CbGpPWpGaD
Amiloride—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00119	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—chronic obstructive pulmonary disease	0.0001	0.000989	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.95e-05	0.000981	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	9.79e-05	0.000966	CbGpPWpGaD
Amiloride—Shock—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.00112	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	9.46e-05	0.000933	CbGpPWpGaD
Amiloride—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.00109	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.27e-05	0.000914	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.01e-05	0.000889	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.00104	CcSEcCtD
Amiloride—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.95e-05	0.00104	CcSEcCtD
Amiloride—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.00103	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.86e-05	0.000874	CbGpPWpGaD
Amiloride—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.00103	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.00101	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	8.57e-05	0.000845	CbGpPWpGaD
Amiloride—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000993	CcSEcCtD
Amiloride—Rash—Prednisolone—chronic obstructive pulmonary disease	8.53e-05	0.000991	CcSEcCtD
Amiloride—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.53e-05	0.00099	CcSEcCtD
Amiloride—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.000985	CcSEcCtD
Amiloride—Headache—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.000985	CcSEcCtD
Amiloride—Constipation—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000977	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.26e-05	0.000815	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.00081	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.00081	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.00081	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.00081	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.00081	CbGpPWpGaD
Amiloride—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.1e-05	0.000941	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	8.05e-05	0.000794	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000934	CcSEcCtD
Amiloride—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.04e-05	0.000934	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	7.98e-05	0.000787	CbGpPWpGaD
Amiloride—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000903	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	7.5e-05	0.00074	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MMP1—chronic obstructive pulmonary disease	7.44e-05	0.000734	CbGpPWpGaD
Amiloride—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000819	CcSEcCtD
Amiloride—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000808	CcSEcCtD
Amiloride—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000781	CcSEcCtD
Amiloride—PLAU—Hemostasis—NOS2—chronic obstructive pulmonary disease	6.71e-05	0.000662	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	6.56e-05	0.000647	CbGpPWpGaD
Amiloride—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000755	CcSEcCtD
Amiloride—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000726	CcSEcCtD
Amiloride—Rash—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.00072	CcSEcCtD
Amiloride—SLC9A1—Disease—HDAC2—chronic obstructive pulmonary disease	6.2e-05	0.000611	CbGpPWpGaD
Amiloride—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000719	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.18e-05	0.000609	CbGpPWpGaD
Amiloride—Headache—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000715	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	6.12e-05	0.000603	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.1e-05	0.000602	CbGpPWpGaD
Amiloride—Nausea—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000678	CcSEcCtD
Amiloride—SLC9A1—Disease—KL—chronic obstructive pulmonary disease	5.76e-05	0.000568	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	5.65e-05	0.000557	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—chronic obstructive pulmonary disease	5.64e-05	0.000556	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.57e-05	0.000549	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.41e-05	0.000534	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS3—chronic obstructive pulmonary disease	5.39e-05	0.000532	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.13e-05	0.000506	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.87e-05	0.000481	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB3—chronic obstructive pulmonary disease	4.32e-05	0.000426	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000422	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.22e-05	0.000416	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.12e-05	0.000407	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.93e-05	0.000388	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.89e-05	0.000383	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.8e-05	0.000375	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.000368	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—chronic obstructive pulmonary disease	3.6e-05	0.000355	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.57e-05	0.000352	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.54e-05	0.000349	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.03e-05	0.000299	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—chronic obstructive pulmonary disease	2.94e-05	0.00029	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—chronic obstructive pulmonary disease	2.9e-05	0.000286	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.53e-05	0.00025	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.52e-05	0.000248	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000244	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	2.45e-05	0.000241	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.42e-05	0.000239	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.34e-05	0.000231	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000227	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	2.28e-05	0.000225	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.27e-05	0.000224	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000212	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.12e-05	0.000209	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.95e-05	0.000192	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—chronic obstructive pulmonary disease	1.91e-05	0.000189	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.000185	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.82e-05	0.000179	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.34e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.32e-05	0.00013	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.25e-05	0.000123	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000119	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000111	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.04e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.27e-06	9.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.14e-06	9.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.64e-06	8.52e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.52e-06	8.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.51e-06	8.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.07e-06	7.96e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.94e-06	7.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.52e-06	7.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.49e-06	5.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.25e-06	5.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.11e-06	5.04e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.89e-06	4.82e-05	CbGpPWpGaD
